中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
3期
443-444
,共2页
丁涤非%胡凯%苏兆顶%王玉生%束劲松
丁滌非%鬍凱%囌兆頂%王玉生%束勁鬆
정조비%호개%소조정%왕옥생%속경송
癌,非小细胞肺癌%放射疗法,适形%化学疗法
癌,非小細胞肺癌%放射療法,適形%化學療法
암,비소세포폐암%방사요법,괄형%화학요법
Carcinoma,non-small-cell lung%Radiotherapy,conformal%Chemotherapy
目的 观察三维适形放射治疗(3DCRT)配合化疗治疗局部晚期(NSCLC)的近期疗效及毒副反应.方法 36例局部晚期NSCLC(Ⅲa或HI b期)进入三维适形放射治疗加化疗组,均行NP方案化疗并加3DCRT同步治疗.结果 36例均完成治疗计划,肺原发灶总有效率为91.7%,纵隔转移淋巴结总有效率为100%,白细胞下降发生率为94.4%,放射性食管炎和放射性肺炎的发生率分别为52.8%、11.1%,均为1、2级.结论 三维适形放射治疗配合化疗治疗局部晚期非小细胞肺癌能为绝大数患者耐受,近期疗效满意.
目的 觀察三維適形放射治療(3DCRT)配閤化療治療跼部晚期(NSCLC)的近期療效及毒副反應.方法 36例跼部晚期NSCLC(Ⅲa或HI b期)進入三維適形放射治療加化療組,均行NP方案化療併加3DCRT同步治療.結果 36例均完成治療計劃,肺原髮竈總有效率為91.7%,縱隔轉移淋巴結總有效率為100%,白細胞下降髮生率為94.4%,放射性食管炎和放射性肺炎的髮生率分彆為52.8%、11.1%,均為1、2級.結論 三維適形放射治療配閤化療治療跼部晚期非小細胞肺癌能為絕大數患者耐受,近期療效滿意.
목적 관찰삼유괄형방사치료(3DCRT)배합화료치료국부만기(NSCLC)적근기료효급독부반응.방법 36례국부만기NSCLC(Ⅲa혹HI b기)진입삼유괄형방사치료가화료조,균행NP방안화료병가3DCRT동보치료.결과 36례균완성치료계화,폐원발조총유효솔위91.7%,종격전이림파결총유효솔위100%,백세포하강발생솔위94.4%,방사성식관염화방사성폐염적발생솔분별위52.8%、11.1%,균위1、2급.결론 삼유괄형방사치료배합화료치료국부만기비소세포폐암능위절대수환자내수,근기료효만의.
Objective To evaluate the acute side effects and efficacy of three dimensional conformal radiotherapy(3DCRT)combined with chemotherapy(CT)for locally advance non-small cell lung cancer(NSCLC).Methods from May.2002 tO Dec 2004,36 patients with NSCLC were treated with three dimensional-conformal radiotherapy combined with chemotherapy navelbine+cisplafin(NP)Results The overall response rate(CR+PR)was 91.7% for the primary tumor,and 100%for metastases mediastinal lymph mode.The leucopenia mte was 94.4%(55.6%Grade 3.4)Acute radiation esophagitis occurred in 52.8%of patients(Grade 1.2)Acute radiation pneumonitis was observed in 11.1%of patients(Grade 1.2)Conclusion 3DCRT combined with CT is well tolerated in most patients with NSCLC.Its early responses are milder than the conventional radiotherapy combined with chemotherapy.Remote results awmt further follow-up